--- title: "12 Health Care Stocks Moving In Wednesday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/274043580.md" description: "In Wednesday's after-market session, several health care stocks experienced notable movements. Gainers included Lyra Therapeutics (LYRA) up 4.9% to $2.15, Cassava Sciences (SAVA) up 3.41% to $2.11, and Achieve Life Sciences (ACHV) up 3.21% to $4.5. Conversely, 60 Degrees (SXTP) saw a decline of 5.8% to $4.9, while AIM ImmunoTech (AIM) fell 3.28% to $1.18. Other notable losers included Shuttle Pharmaceuticals (SHPH) and Scienture Holdings (SCNX), both down 3.22%." datetime: "2026-01-28T21:05:50.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274043580.md) - [en](https://longbridge.com/en/news/274043580.md) - [zh-HK](https://longbridge.com/zh-HK/news/274043580.md) --- # 12 Health Care Stocks Moving In Wednesday's After-Market Session ### Gainers - **Lyra Therapeutics** (NASDAQ:LYRA) stock moved upwards by 4.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $3.0 million. - **Cassava Sciences** (NASDAQ:SAVA) shares increased by 3.41% to $2.11. The company's market cap stands at $102.4 million. - **Achieve Life Sciences** (NASDAQ:ACHV) shares increased by 3.21% to $4.5. The market value of their outstanding shares is at $245.4 million. - **Nektar Therapeutics** (NASDAQ:NKTR) shares rose 2.95% to $36.97. The market value of their outstanding shares is at $773.5 million. - **AlphaTON Capital** (NASDAQ:ATON) stock rose 2.88% to $0.68. The market value of their outstanding shares is at $7.9 million. - **TScan Therapeutics** (NASDAQ:TCRX) stock increased by 2.83% to $1.09. The company's market cap stands at $63.5 million. ### Losers - **60 Degrees** (NASDAQ:SXTP) shares decreased by 5.8% to $4.9 during Wednesday's after-market session. The company's market cap stands at $6.2 million. - **AIM ImmunoTech** (AMEX:AIM) shares fell 3.28% to $1.18. The company's market cap stands at $3.8 million. - **Shuttle Pharmaceuticals** (NASDAQ:SHPH) shares decreased by 3.22% to $2.11. The company's market cap stands at $3.2 million. - **Scienture Holdings** (NASDAQ:SCNX) shares decreased by 3.22% to $0.48. The market value of their outstanding shares is at $20.3 million. - **Oragenics** (AMEX:OGEN) shares decreased by 2.96% to $0.8. The company's market cap stands at $3.3 million. - **Psyence Biomedical** (NASDAQ:PBM) shares fell 2.59% to $0.75. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md) - [ACHV.US](https://longbridge.com/en/quote/ACHV.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [LYRA.US](https://longbridge.com/en/quote/LYRA.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [AIM.US](https://longbridge.com/en/quote/AIM.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [SAVA.US](https://longbridge.com/en/quote/SAVA.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [SCNX.US](https://longbridge.com/en/quote/SCNX.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md) - [FLNA.US](https://longbridge.com/en/quote/FLNA.US.md) ## Related News & Research - [60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement](https://longbridge.com/en/news/294876524.md) - [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md) - [AIM ImmunoTech completes last dosing in Phase 2 DURIPANC trial of Ampligen plus AstraZeneca Imfinzi in metastatic pancreatic cancer](https://longbridge.com/en/news/294694088.md) - [Achieve Life Sciences posts corporate presentation on cytisinicline smoking-cessation program](https://longbridge.com/en/news/294242731.md) - [60 Degrees Pharma hits minimum enrollment trigger for interim readout in severe babesiosis tafenoquine trial](https://longbridge.com/en/news/294254910.md)